Amicus Therapeutics Inc’s recently made public that its President and CEO Campbell Bradley L unloaded Company’s shares for reported $4000.0 on Feb 19 ’25. In the deal valued at $10.00 per share,400 shares were sold. As a result of this transaction, Campbell Bradley L now holds 1,150,657 shares worth roughly $10.22 million.
Then, BRADLEY CAMPBELL bought 400 shares, generating $3,940 in total proceeds.
Before that, Campbell Bradley L sold 7,500 shares. Amicus Therapeutics Inc shares valued at $75,124 were divested by the President and CEO at a price of $10.02 per share. As a result of the transaction, Campbell Bradley L now holds 886,654 shares, worth roughly $7.87 million.
Morgan Stanley downgraded its Amicus Therapeutics Inc [FOLD] rating to an Equal-weight from a an Overweight in a research note published on December 13, 2024; the price target was decreased to $12 from $17. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early September with a ‘”a Buy”‘ rating. Wells Fargo began covering FOLD with “an Overweight” recommendation on May 30, 2024. Guggenheim revised its rating on May 14, 2024. It rated FOLD as “a Buy” which previously was an “a Neutral”.
Price Performance Review of FOLD
On Tuesday, Amicus Therapeutics Inc [NASDAQ:FOLD] saw its stock jump 2.90% to $8.88. Over the last five days, the stock has lost -2.52%. Amicus Therapeutics Inc shares have fallen nearly -5.73% since the year began. Nevertheless, the stocks have fallen -27.75% over the past one year. While a 52-week high of $12.65 was reached on 02/19/25, a 52-week low of $8.55 was recorded on 03/10/25. SMA at 50 days reached $9.41, while 200 days put it at $10.27.
Levels Of Support And Resistance For FOLD Stock
The 24-hour chart illustrates a support level at 8.65, which if violated will result in even more drops to 8.41. On the upside, there is a resistance level at 9.04. A further resistance level may holdings at 9.19. The Relative Strength Index (RSI) on the 14-day chart is 40.76, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.41%. Stochastics %K at 13.81% indicates the stock is a buying.
